Replimune Limited v. Amgen Inc.

IPR2023-00106 | Patent Trial and Appeal Board

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed Nov. 2, 2022
Terminated Sept. 13, 2023
Judges Cynthia Hardman, Jamie Wisz, and Kristi Sawert
Case Type Inter Partes Review
Status Terminated-Settled
Challenged Patent 14/424,424
Patent No. 10,034,938 assignments
Tech Center 1600
Art Unit 1648
Inventors Ari Vanderwalde, Mohamed Shabooti
Last Updated: 5 hours ago
Filing Date # Filing and Exhibits
9/13/202309-13-2023-Board
Board Termination Decision: Post-DI Settlement 20:
9/6/202309-06-2023-Patent_Owner
9/1/202309-01-2023-Petitioner
Petitioner Motion: Motion to terminate due to settlement (post DI) 17:
Petitioner Other: other 18:
8/18/202308-18-2023-Patent_Owner
Patent Owner Notice: Notice of deposition 16:
7/25/202307-25-2023-Patent_Owner
7/13/202307-13-2023-Patent_Owner
Patent Owner Notice: Notice of deposition 14:
6/1/202306-01-2023-Patent_Owner
Patent Owner Other: other 13:
5/18/202305-18-2023-Board
Board Order: Other 12:
3/23/202303-23-2023-Patent_Owner
3/16/202303-16-2023-Petitioner
2/22/202302-22-2023-Patent_Owner
Patent Owner POPR: filed 8:
1/6/202301-06-2023-Patent_Owner
Patent Owner Notice: Power of Attorney 6:
Patent Owner Notice: Updated Mandatory Notice 7:
11/22/202211-22-2022-Board
Board Notice: Notice filing date accorded 5:
11/21/202211-21-2022-Patent_Owner
Patent Owner Notice: Mandatory Notice 3:
Patent Owner Notice: Power of Attorney 4:
11/2/202211-02-2022-Petitioner
Petitioner Petition: as filed 1:
Petitioner Notice: Power of Attorney 2: